161 related articles for article (PubMed ID: 7167529)
1. Regional hyperthermic perfusion for malignant melanoma.
Hafström LO; Ehrson H; Hugander A; Jönsson PE; Westling H
Prog Clin Biol Res; 1982; 107():793-8. PubMed ID: 7167529
[No Abstract] [Full Text] [Related]
2. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
Tonak J; Hohenberger W; Göhl J
Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
[No Abstract] [Full Text] [Related]
3. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
Hafström L; Jönsson PE
Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
[TBL] [Abstract][Full Text] [Related]
4. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic perfusion with chemotherapy for cancers of the extremities.
Stehlin JS
Surg Gynecol Obstet; 1969 Aug; 129(2):305-8. PubMed ID: 5815841
[No Abstract] [Full Text] [Related]
6. [New modifications in isolated extremity perfusion ].
Aigner K; Hild P; Hundeiker M
Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
[TBL] [Abstract][Full Text] [Related]
7. Isolated limb perfusion for malignant melanoma.
Rosin RD; Westbury G
Practitioner; 1980 Oct; 224(1348):1031-6. PubMed ID: 7220430
[No Abstract] [Full Text] [Related]
8. [Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].
Ghussen F; Nagel K; Groth W
Dtsch Med Wochenschr; 1981 Nov; 106(48):1612-5. PubMed ID: 7308000
[TBL] [Abstract][Full Text] [Related]
9. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
Ghussen F; Nagel K
Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
[TBL] [Abstract][Full Text] [Related]
10. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
Kettelhack C; Hohenberger P; Schlag PM
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
[TBL] [Abstract][Full Text] [Related]
11. [Changes of malignant melanoma cells caused by isolated hyperthermic perfusion therapy--electron microscopic and fluorescence histochemical investigations].
Ishii M; Paul E; Aigner K; Illig L
Nihon Hifuka Gakkai Zasshi; 1983 Sep; 93(10):1037-44. PubMed ID: 6663790
[No Abstract] [Full Text] [Related]
12. Results of eleven years' experience with heated perfusion for melanoma of the extremities.
Stehlin JS; Giovanella BC; de Ipolyi PD; Anderson RF
Cancer Res; 1979 Jun; 39(6 Pt 2):2255-7. PubMed ID: 445425
[TBL] [Abstract][Full Text] [Related]
13. [Value of isolation-perfusion of the limbs in melanomas and sarcomas].
Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Kroon B
Ann Chir; 1995; 49(1):9-12. PubMed ID: 7741477
[No Abstract] [Full Text] [Related]
14. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.
Martijn H; Oldhoff J; Koops HS
J Surg Oncol; 1982 May; 20(1):9-13. PubMed ID: 7078190
[TBL] [Abstract][Full Text] [Related]
15. Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs.
Vrouenraets BC; Eggermont AM; Klaase JM; Van Geel BN; Van Dongen JA; Kroon BB
Eur J Surg Oncol; 1994 Dec; 20(6):681-5. PubMed ID: 7995421
[TBL] [Abstract][Full Text] [Related]
16. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
[TBL] [Abstract][Full Text] [Related]
17. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
[No Abstract] [Full Text] [Related]
18. Anesthesia for isolated limb perfusion.
Cruchley PM; Kaplan JA; Waller JL; Young MR
Anesthesiology; 1982 Sep; 57(3):228-30. PubMed ID: 7114546
[No Abstract] [Full Text] [Related]
19. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
[TBL] [Abstract][Full Text] [Related]
20. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
